Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth E Rosenzweig

Showing results (1-10 of 151) with videos related to

Pageof 16
Sort By:
Thoracic Surgery Clinics|October 5, 2020
Radiation Therapy for Malignant Pleural MesotheliomaKenneth E Rosenzweig
Seminars in Thoracic and Cardiovascular Surgery|December 17, 2013
Current readings: improvements in intensity-modulated radiation therapy for malignant pleural mesotheliomaKenneth E Rosenzweig
Annals of Translational Medicine|July 15, 2017
Malignant pleural mesothelioma: adjuvant therapy with radiation therapyKenneth E Rosenzweig
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 20, 2007
Palliative radiation for lung cancer metastases to the breast: two case reportsAndreas Rimner, Kenneth E Rosenzweig
Annals of Cardiothoracic Surgery|August 27, 2013
Novel radiation therapy approaches in malignant pleural mesotheliomaAndreas Rimner, Kenneth E Rosenzweig
Clinical Thyroidology|January 6, 2015
Cold Climate Is a Risk Factor for Thyroid CancerSteven Lehrer, Kenneth E Rosenzweig
Clinical Lung Cancer|December 3, 2014
Lung cancer hormesis in high impact states where nuclear testing occurredSteven Lehrer, Kenneth E Rosenzweig
Cancer|February 26, 2015
Wilms tumor and breast cancerSteven Lehrer, Kenneth E Rosenzweig
Translational Lung Cancer Research|February 22, 2019
The evolving toxicity profile of SBRT for lung cancerMarcher Thompson, Kenneth E Rosenzweig
Cancer|June 11, 2016
Being a widower may be an indication for routine prostate-specific antigen screening above age 69 years, which the American Urological Association recommends as a cutoff pointSteven Lehrer, Kenneth E Rosenzweig
Pageof 16

Showing results (1-10 of 151) with videos related to

Sort By:
Pageof 16
Thoracic Surgery Clinics|October 5, 2020
Radiation Therapy for Malignant Pleural MesotheliomaKenneth E Rosenzweig
Seminars in Thoracic and Cardiovascular Surgery|December 17, 2013
Current readings: improvements in intensity-modulated radiation therapy for malignant pleural mesotheliomaKenneth E Rosenzweig
Annals of Translational Medicine|July 15, 2017
Malignant pleural mesothelioma: adjuvant therapy with radiation therapyKenneth E Rosenzweig
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 20, 2007
Palliative radiation for lung cancer metastases to the breast: two case reportsAndreas Rimner, Kenneth E Rosenzweig
Annals of Cardiothoracic Surgery|August 27, 2013
Novel radiation therapy approaches in malignant pleural mesotheliomaAndreas Rimner, Kenneth E Rosenzweig
Clinical Thyroidology|January 6, 2015
Cold Climate Is a Risk Factor for Thyroid CancerSteven Lehrer, Kenneth E Rosenzweig
Clinical Lung Cancer|December 3, 2014
Lung cancer hormesis in high impact states where nuclear testing occurredSteven Lehrer, Kenneth E Rosenzweig
Cancer|February 26, 2015
Wilms tumor and breast cancerSteven Lehrer, Kenneth E Rosenzweig
Translational Lung Cancer Research|February 22, 2019
The evolving toxicity profile of SBRT for lung cancerMarcher Thompson, Kenneth E Rosenzweig
Cancer|June 11, 2016
Being a widower may be an indication for routine prostate-specific antigen screening above age 69 years, which the American Urological Association recommends as a cutoff pointSteven Lehrer, Kenneth E Rosenzweig
Pageof 16